Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases

首圖

INGELHEIM, Germany & WAEDENSWIL, Switzerland--(BUSINESS WIRE)--Boehringer Ingelheim and Numab Therapeutics (Numab) today announced that they have entered into a research collabora......